Lanean...
Target Therapy in Hematological Malignances: New Monoclonal Antibodies
Apart from radio- and chemotherapy, monoclonal antibodies (MoAbs) represent a new, more selective tool in the treatment of hematological malignancies. MoAbs bind with the specific antigens of the tumors. This interaction is a basis for targeted therapies which exhibit few side effects and significan...
Gorde:
| Argitaratua izan da: | Int Sch Res Notices |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hindawi Publishing Corporation
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4897146/ https://ncbi.nlm.nih.gov/pubmed/27433507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/701493 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|